Can a daily supplement help the body clear HPV?

NCT ID NCT07755566

Completed Disease control Sponsor: Hifas da Terra S.L. Source: ClinicalTrials.gov ↗

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial tests whether a daily oral supplement called Papilozumib can positively change the vaginal and gut bacteria in women who test positive for human papillomavirus (HPV). Over three months, 21 women aged 30-65 will take three capsules daily. Researchers will measure changes in microbiota, HPV clearance, and vaginal health to see if the supplement offers any benefit.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Papilozumib, an oral synbiotic supplement with mushroom extracts, probiotics, vitamins, and minerals
What this could lead to: If successful, this supplement could offer a natural way to support HPV clearance and improve vaginal health.
What could go wrong: This is a small, early-stage trial without a placebo group, so results may not be conclusive or widely applicable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAPILLOMAVIRUS INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

human papilloma virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PAPILLOMAVIRUS INFECTIONS

Contacts and locations

Locations

Instituto Palacios, Salud y Medicina de la Mujer

Madrid, Madrid, 28009, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.